Summary
Most indication and general medication statements are supported by the provided label excerpts; however, several safety/side-effect and monitoring-related claims are only partially supported or not explicitly supported as stated (e.g., specific side effects and “prompt medical care” phrasing).
Category Scores
Accurate Statements
Amlodipine tablets are a prescription medicine used to treat high blood pressure (hypertension).
Section 1: “Amlodipine is indicated for the treatment of hypertension.”
Amlodipine tablets are a prescription medicine used to treat certain types of chest pain (angina).
Section 1: Chronic stable angina and vasospastic angina indications.
Amlodipine is a calcium channel blocker.
Section 12/Mechanism: “inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.”
Amlodipine relaxes blood vessels.
Section 12: “peripheral arterial vasodilator… reduction in peripheral vascular resistance and reduction in blood pressure.”
Amlodipine helps lower blood pressure.
Section 12: “reduction in… blood pressure.” and Section 14 hypertension outcome.
Amlodipine improves blood flow to the heart.
Supported indirectly by Section 1 indications for angina and Section 14 angina trial outcomes; label excerpts emphasize symptomatic treatment and reduced angina attacks/reduced hospitalization but do not explicitly use the phrase “improves blood flow to the heart.”
Amlodipine is used for chronic (stable) angina.
Section 1: “Chronic Stable Angina… indicated for the symptomatic treatment.”
Amlodipine is used for vasospastic (Prinzmetal’s) angina.
Section 1: “Vasospastic Angina (Prinzmetal's or Variant Angina)… indicated.”
Amlodipine is typically taken by mouth once daily.
Section 2: “usual initial… oral dose… 5 mg once daily” and generally once daily dosing.
The dose of amlodipine is set by the prescriber based on the patient’s condition and response.
Section 2: “Dosage should be adjusted according to each patient's need.”
Common side effects of amlodipine include swelling in the ankles or feet (peripheral edema).
Section 6: “The most common side effects are headache and edema.”
Common side effects of amlodipine include dizziness.
Not explicitly supported in provided excerpts of Section 6.
Common side effects of amlodipine include flushing.
Not explicitly supported in provided excerpts of Section 6.
Patients should seek medical advice if they develop severe symptoms or signs of an allergic reaction while taking amlodipine.
Partially supported: Section 4 only includes contraindication for known sensitivity; Section 6 includes angioedema/rash but provided excerpts do not specify “seek medical advice” wording or “severe symptoms” guidance.
Dosing and monitoring may differ for patients with liver disease while taking amlodipine.
Section 2: hepatic insufficiency may start at 2.5 mg once daily; Section 5: “caution… severe hepatic impairment.”
Worsening chest pain or new symptoms in a patient taking amlodipine should prompt medical care promptly.
Partially supported: Section 5 “Rarely… increased frequency, duration and/or severity of angina or acute myocardial infarction… on starting… or dosage increase.” Provided excerpts do not explicitly instruct “prompt medical care”.
Unsupported Statements
Amlodipine improves blood flow to the heart.
Not explicitly stated in the provided label excerpts; label emphasizes vasodilation and angina outcomes without explicitly claiming improved coronary blood flow.
Common side effects of amlodipine include dizziness.
The provided Section 6 excerpt lists “headache and edema” as most common and does not explicitly list dizziness.
Common side effects of amlodipine include flushing.
The provided Section 6 excerpt does not explicitly list flushing.
Patients should seek medical advice if they develop severe symptoms or signs of an allergic reaction while taking amlodipine.
The provided excerpts do not include explicit patient-action instructions or “signs of an allergic reaction” phrasing.
Dosing and monitoring may differ for patients with heart rhythm problems while taking amlodipine.
No label excerpt provided specifically addressing “heart rhythm problems” with dosing/monitoring differences.
Dosing and monitoring may differ for patients with severe low blood pressure while taking amlodipine.
No label excerpt provided specifically addressing dosing/monitoring differences for “severe low blood pressure.” (Section 5 mentions acute hypotension has rarely been reported, but does not state monitoring/dosing differences as claimed.)
Contradictions
Important Omissions
Label contraindication is amlodipine contraindicated in patients with known sensitivity to amlodipine; the claims provided do not mention contraindications at all.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Claims are largely consistent with general labeled indications and dosing frequency; however, specific side-effect and patient-action/monitoring statements were not fully supported by provided label excerpts, creating some risk of misinforming patient expectations rather than directly contradicting contraindications.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
Several claims (dizziness/flushing as common side effects; specific monitoring-dosing differences for heart rhythm problems and severe low blood pressure; “prompt medical care” wording) are not explicitly supported by the provided label excerpts.
Suggested Improvement
Limit side-effect claims to those explicitly listed as most common in the provided label (headache and edema) and remove or rephrase unsupported monitoring/prompt-care statements unless directly supported by the label text.